Global GLP-1 Receptor Agonist Market Research Report (up to 2027)
Global GLP-1 Receptor Agonist Market (up to 2027): By Product, Drug Class, Route of Administration, Application, Distribution Channel, and Region
The market research report by 360iResearch forecasts that the global GLP-1 receptor agonist market size will grow from $3,632.28 million in 2021 to $4,016.94 million in 2022, and further increase at an average annual rate of 10.84% to reach $6,737.14 million by 2027. This report provides a comprehensive analysis of the global GLP-1 receptor agonist market, including sections on introduction, research methodology, executive summary, market overview, market insights, product analysis (including Bidurian, Ozempic, Saxenda, Trulicity, and Victoza), drug classification analysis (including Albiglutide, Dulaglutide, Exenatide, Liraglutide, and Lixisenatide), route of administration analysis (oral and non-oral), application analysis (including liver cirrhosis, non-alcoholic fatty liver disease, obesity, and type 2 diabetes), regional analysis (including North and South America, the United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, the United Kingdom, Germany, France, Russia, and others), competitive landscape, and company information.
- Company：マーケットリサーチセンター
- Price：Other
